There is a compelling need for new approaches to prevention and control of periodontitis. A vaccine may be feasible, especially in highly susceptible groups and individuals. The humoral immune response can be protective and can alter the course of periodontal destruction. This multidisciplinary Program Project proposes to continue to obtain answers to fundamental questions about the immune response to antigens of periodontopathic bacteria, and to work toward development of a vaccine. We will more completely characterize the nonhuman primate model in which we successfully suppressed the progress of periodontitis by immunization. Using the same vaccine and a similar protocol as previously, we will add 28 animals to the 20 already studied. We will induce periodontitis by ligature placement as before, but extend the protocol to evaluate the consequence of ligature removal and superinfection. We will characterize the subgingival flora at baseline and monitor not only Porphyromonas gingivalis but also several species of putative pathogens throughout the study. Clinical manifestations of periodontitis will be recorded and alveolar bone status assessed by digital subtraction radiography. Serum, gingival fluid, and saliva antibody titers and serum antibody avidities for antigens of P. gingivalis will be monitored, and related to disease outcome. We will complete identification and characterization of major cell envelope antigens of A. actinomycetemcomitans, P. gingivalis, and Bacteroides forsythus, and use these antigens to measure IgG titers and subclass in patient and control sera before and after treatment. The protein antigens will be immunologically characterized in rabbits and monkeys to identify those with the greatest potential for future use in a vaccine. The periodontal pathogens have shared antigenic epitopes located in lipopolysaccharide (LPS). We will prepare anti-idiotype vaccines to these epitopes and test their capacity to induce protection. We have evidence that mechanisms other than opsonization are responsible for antibody suppression of alveolar bone resorption. These will be investigated by studying in detail the role of P. gingivalis antigens and serum antibodies on activation and suppression of macrophage and expression of E selectin by endothelial cells. Successful completion of these studies will provide the fundamental information required to develop a vaccine for human periodontitis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Program Projects (P01)
Project #
5P01DE008555-08
Application #
2391199
Study Section
Special Emphasis Panel (ZDE1-PW (01))
Project Start
1989-07-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Dentistry
Type
Schools of Dentistry
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Pawlowski, Adrian P; Chen, Allen; Hacker, Beth M et al. (2005) Clinical effects of scaling and root planing on untreated teeth. J Clin Periodontol 32:21-8
Roberts, Frank A; Houston, Laura S; Lukehart, Sheila A et al. (2004) Periodontitis vaccine decreases local prostaglandin E2 levels in a primate model. Infect Immun 72:1166-8
Yang, E Y; Tanner, A C R; Milgrom, P et al. (2002) Periodontal pathogen detection in gingiva/tooth and tongue flora samples from 18- to 48-month-old children and periodontal status of their mothers. Oral Microbiol Immunol 17:55-9
Tanner, A C R; Milgrom, P M; Kent Jr, R et al. (2002) The microbiota of young children from tooth and tongue samples. J Dent Res 81:53-7
Tanner, A C R; Milgrom, P M; Kent Jr, R et al. (2002) Similarity of the oral microbiota of pre-school children with that of their caregivers in a population-based study. Oral Microbiol Immunol 17:379-87
Robinovitch, M R; Ashley, R L; Iversen, J M et al. (2001) Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity. Oral Dis 7:86-93
Fan, Q; Sims, T; Sojar, H et al. (2001) Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes. Oral Microbiol Immunol 16:144-52
Nakagawa, T; Sims, T; Fan, Q et al. (2001) Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis. Oral Microbiol Immunol 16:202-11
Sims, T J; Schifferle, R E; Ali, R W et al. (2001) Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. Oral Microbiol Immunol 16:193-201
Fan, Q; Sims, T J; Nakagawa, T et al. (2000) Antigenic cross-reactivity among Porphyromonas gingivalis serotypes. Oral Microbiol Immunol 15:158-65

Showing the most recent 10 out of 46 publications